2iz3
From Proteopedia
(Difference between revisions)
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==Solution structure of human beta-microseminoprotein== | ==Solution structure of human beta-microseminoprotein== | ||
- | <StructureSection load='2iz3' size='340' side='right'caption='[[2iz3 | + | <StructureSection load='2iz3' size='340' side='right'caption='[[2iz3]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2iz3]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2iz3]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2IZ3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2IZ3 FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 10 models</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2iz3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2iz3 OCA], [https://pdbe.org/2iz3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2iz3 RCSB], [https://www.ebi.ac.uk/pdbsum/2iz3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2iz3 ProSAT]</span></td></tr> |
</table> | </table> | ||
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/MSMB_HUMAN MSMB_HUMAN] Defects in MSMB are the cause of susceptibility to prostate cancer hereditary type 13 (HPC13) [MIM:[https://omim.org/entry/611928 611928]. It is a condition associated with familial predisposition to cancer of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/MSMB_HUMAN MSMB_HUMAN] | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 12: | Line 16: | ||
<jmolCheckbox> | <jmolCheckbox> | ||
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/iz/2iz3_consurf.spt"</scriptWhenChecked> | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/iz/2iz3_consurf.spt"</scriptWhenChecked> | ||
- | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/ | + | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked> |
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
</jmolCheckbox> | </jmolCheckbox> | ||
Line 30: | Line 34: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Drakenberg | + | [[Category: Drakenberg T]] |
- | [[Category: Fernlund | + | [[Category: Fernlund P]] |
- | [[Category: Ghasriani | + | [[Category: Ghasriani H]] |
- | [[Category: Johnsson | + | [[Category: Johnsson Y]] |
- | [[Category: Teilum | + | [[Category: Teilum K]] |
- | + | ||
- | + | ||
- | + |
Current revision
Solution structure of human beta-microseminoprotein
|